A new clinical trial reveals that low-dose lithium aspartate is ineffective for long COVID brain fog and fatigue, yet exploratory results suggest that higher doses could hold future potential for relief.
Study: Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction. Image Credit: Yellow_man / Shutterstock
A recent study published in JAMA Network Open investigated the effects of lithium aspartate on neurologic symptoms of post-coronavirus disease 2019 (COVID-19) condition (PCC).
PCC or long COVID is the persistence of symptoms for at least four weeks after recovery from initial COVID-19. PCC symptoms last for over six months in about 10% of patients, with post-exertional malaise, cognitive dysfunction, and fatigue being the most common symptoms. Neuroimaging and autopsy data support…